A Phase II trial of AR1001 for Vascular dementia.

Trial Profile

A Phase II trial of AR1001 for Vascular dementia.

Phase of Trial: Phase II

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs AR 1001 (Primary)
  • Indications Vascular dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2016 New trial record
    • 01 Jun 2016 According to an AriBio media release, this trial will be lodged to FDA by 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top